Position in FTRE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,339
+$8,411 QoQ
Shares Held
1,054
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#232
of 331 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Siemens Fonds Invest GmbH holds $11,160,612 across 7 Biotechnology names. FTRE ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,930 | $5,925,988 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,060 | $3,155,112 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,919 | $878,706 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
2,339 | $438,047 | |
| 5 | INCY |
Incyte Corp
|
3,670 | $416,031 | |
| 6 | INSM |
INSMED Inc
|
3,080 | $328,389 | |
| 7 | FTRE |
Fortrea Holdings Inc.
This page
|
1,054 | $18,339 |
All Filings in FTRE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,339 | 1,054 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,928 | 1,054 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,181 | 1,054 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,720 | 1,392 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,876 | 1,392 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,509 | 1,392 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||